Squarepoint’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
33,324
-15,865
| -32% | -$692K | ﹤0.01% | 1313 |
|
|
2025
Q1 | $1.35M | Buy |
49,189
+815
| +2% | +$22.3K | ﹤0.01% | 1354 |
|
|
2024
Q4 | $1.95M | Sell |
48,374
-25,151
| -34% | -$1.01M | ﹤0.01% | 1180 |
|
|
2024
Q3 | $3.48M | Sell |
73,525
-35,038
| -32% | -$1.66M | 0.01% | 893 |
|
|
2024
Q2 | $3.24M | Buy |
108,563
+23,312
| +27% | +$696K | 0.01% | 856 |
|
|
2024
Q1 | $3.43M | Buy |
85,251
+57,053
| +202% | +$2.29M | 0.01% | 844 |
|
|
2023
Q4 | $718K | Sell |
28,198
-2,190
| -7% | -$55.8K | ﹤0.01% | 1506 |
|
|
2023
Q3 | $422K | Buy |
+30,388
| New | +$422K | ﹤0.01% | 1730 |
|
|
2023
Q1 | – | Sell |
-21,878
| Closed | -$546K | – | 2530 |
|
|
2022
Q4 | $546K | Sell |
21,878
-97,003
| -82% | -$2.42M | ﹤0.01% | 1412 |
|
|
2022
Q3 | $2.59M | Buy |
118,881
+39,553
| +50% | +$861K | 0.01% | 684 |
|
|
2022
Q2 | $1.56M | Buy |
+79,328
| New | +$1.56M | 0.01% | 855 |
|
|
2021
Q4 | – | Sell |
-14,499
| Closed | -$852K | – | 2682 |
|
|
2021
Q3 | $852K | Sell |
14,499
-34,316
| -70% | -$2.02M | ﹤0.01% | 1145 |
|
|
2021
Q2 | $2.37M | Buy |
48,815
+34,404
| +239% | +$1.67M | 0.01% | 727 |
|
|
2021
Q1 | $560K | Buy |
+14,411
| New | +$560K | ﹤0.01% | 1453 |
|
|
2020
Q4 | – | Sell |
-9,045
| Closed | -$292K | – | 2722 |
|
|
2020
Q3 | $292K | Buy |
+9,045
| New | +$292K | ﹤0.01% | 1690 |
|